Hydroa Vacciniforme

A vesicular and bullous eruption having a tendency to recur in summer during childhood and commonly appearing on sun-exposed skin. The lesions are surrounded by an erythematous zone and resemble a vaccination. (From Dorland, 27th ed)

Networked: 20 relevant articles (3 outcomes, 0 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1.	T-Cell Lymphoma (Lymphoma, T Cell)
2.	Lymphoma (Lymphomas)
3.	Urticaria (Hives)
4.	Prurigo
5.	Photosensitivity Disorders (Photodermatitis)

Experts

1.	Quiñones, Pilar: 1 article (12/2014)
2.	Vasquez, Liliana: 1 article (12/2014)
3.	Moisés-Alfaro, Celia B: 1 article (12/2014)
4.	Miranda, Roberto N: 1 article (12/2014)
5.	Castillo, Jorge J: 1 article (12/2014)
6.	Morales, Domingo: 1 article (12/2014)
7.	Maza, Iván: 1 article (12/2014)
8.	Gerónimo, Jenny: 1 article (12/2014)
9.	Paredes, Gloria: 1 article (12/2014)
10.	Sánchez, Gadwin: 1 article (12/2014)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Hydroa Vacciniforme:

1.	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/01/2012 - "Efficacy of ω-3 polyunsaturated fatty acids for the treatment of refractory hydroa vacciniforme."
2.	MaxepaIBA 03/01/2001 - "We report a case of hydroa vacciniforme treated successfully with dietary fish oil (Maxepa(R)). "
3.	Subcutaneous panniculitis-like T-cell lymphomaIBA 04/01/2013 - "Session 3 examined other more uncommon non-MF CTCLs, including subcutaneous panniculitis-like T-cell lymphoma, extranodal NK/T-cell lymphoma, hydroa vacciniforme-like T-cell lymphoma, and rare subtypes of primary cutaneous peripheral T-cell lymphoma, not otherwise specified. " 08/01/2000 - "Primary cutaneous involvement was demonstrated in eight of these 19 cases, and we recognized four clinicopathologic subtypes among these eight patients: nasal type NK/T cell lymphoma, three cases; primary cutaneous CD30 positive anaplastic large cell lymphoma, two cases; subcutaneous panniculitis-like T-cell lymphoma, one case; lymphoma with hydroa vacciniforme-like cutaneous lesions, two cases. "
4.	beta Carotene (Betacarotene)FDA Link 01/01/1995 - "Hydroa vacciniforme treated by a combination of beta-carotene and canthaxanthin."
5.	CanthaxanthinIBA 01/01/1995 - "Hydroa vacciniforme treated by a combination of beta-carotene and canthaxanthin."
6.	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/01/1998 - "Hydroa vacciniforme presenting in an adult successfully treated with cyclosporin A."
7.	Urocanic AcidIBA 06/01/1985 - "[Hydroa vacciniforme--urocanic acid content of the horny layer of the epidermis]."
8.	Thalidomide (Thalomid)FDA Link 12/01/2014 - "Thalidomide for the treatment of hydroa vacciniforme-like lymphoma: report of four pediatric cases from Peru."
9.	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/01/2009 - "In 3 patients with hydroa vacciniforme-like lymphoproliferative disease, we demonstrated that 1.7%-25.9% of peripheral lymphocytes were infected with EBV and specifically identified these lymphocytes as CD3(+)CD4(-)CD8(-) gammadelta T cell receptor-positive T cells. "
10.	Pyridoxine (Pyridoxin)FDA LinkGeneric 03/01/1993 - "Thus, the possibility of UVA-induced pyridoxine photosensitization was studied in cultured normal human, hydroa vacciniforme, and xeroderma pigmentosum fibroblasts. "

Therapies and Procedures

1.	Immunotherapy 05/01/2011 - "Long-term remission in a child with refractory EBV(+) hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV(+)-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy."
2.	Transplants (Transplant) 01/01/2008 - "In some cases, however, latent EBV infection may result in diseases such as hydroa vacciniforme, hypersensitivity to mosquito bites, and lymphoproliferative disorders such as plasmablastic lymphoma, oral hairy leukoplakia, and post-transplant lymphoproliferative disorders, particularly in immunocompromised patients. "
3.	Phototherapy (Light Therapy) 06/01/1995 - "Twenty patients with photodermatoses [actinic prurigo (n = 6), hydroa vacciniforme (n = 4), idiopathic solar urticaria (n = 1), amiodarone-induced photosensitivity (n = 1) and a range of cutaneous porphyrias (n = 8)] were treated with a 'hardening' course of narrow-band ultraviolet B (TL-01) phototherapy in springtime. "
4.	Drug Therapy (Chemotherapy) 11/01/1988 - "Permanent cure of hydroa vacciniforme after chemotherapy for Hodgkin's disease."